All obese individuals are not created equal: Insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

Diabetes and Vascular Disease Research

Volumn 2, Issue 3, 2005, Pages 105-112

  Reaven, Gerald ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Cardiovascular disease; Insulin resistance; Obesity; Visceral fat; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FITNESS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEALTH SURVEY; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; RISK ASSESSMENT;

EID: 28144442030     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2005.017     Document Type: Review

References (61)

1. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988 to 1994). Obesity Research 1997;5:542-8.
2. Manson JE, Skerrett PJ, Greenland P, Vanltallie TB. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med 2004;164:249-58.
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2002;285:2486-97.
4. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess death associated with underweight, overweight, and obesity. JAMA 2005;293:1861-7.
5. Gregg EW, Cheng YJ, Cadwell BL et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005;293:1868-74.
6. Olefsky JM, Reaven GM, Farquhar JW. Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism. J Clin Invest 1974;53:64-76.
7. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven GM. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985;248:E286-E291.
8. Ferrannini E, Natali A, Beli P, Cavallo-Perin, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997;100:1166-73.
9. Abbasi F, Brown BWB, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002;40:937-43.
10. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
11. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998;83:2773-6.
12. Zavaroni I, Bonini L, Gasparini P et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: The Barilla factory revisited. Metabolism 1999;48:989-94.
13. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8.
14. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin N Am 2004;33:283-303.
15. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000;23:171-5.
16. Shen S-W, Reaven GM, Farquhar JW. Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J Clin Invest 1970;49:2151-60.
17. Greenfield MS, Doberne L, Kraemer FB, Tobey TA, Reaven GM. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981;30:387-92.
18. Pei D, Jones CNO, Bhargava R, Chen Y-DI, Reaven GM. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 1994;37:843-5.
19. Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 1983;32:408-11.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
21. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_ Metabolic syndrome_definition.pdf
22. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among US adults. Obes Res 2003;11:1223-31.
23. Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism 2005;54:1323-8.
24. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004;53:495-9.
25. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-09.
26. McLaughlin T, Abbasi F, Lamendola C et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002;106:2908-12.
27. Abate N, Garg A, Peshock RM, Stray-Gunderson J, Grundy S. Relationships of generalized and regional adiposity to insulin sensitivity in man. J Clin Invest 1995;96:88-98.
28. Cefalu WT, Wang ZQ, Werbgel S et al. Contribution of visceral fat to the insulin resistance of aging. Metabolism 1995;44:954-9.
29. Macor C, Ruggeri A, Mazzonetto P, Federspil G, Cobelli C, Veiiot R. Visceral adipose tissue impairs insulin secretion and sensitivity, but not energy expenditure in obesity. Metabolism 1997;46:123-9.
30. Goodpaster BH, Thaete JA, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-85.
31. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lbeovitz HE. Body composition, visceral fat, leptin and insulin resistance in Asian Indian Men. J Clin Endocrinol Metab 1999:84:137-44.
32. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-E948.
33. Sites CK, Calles-Escandon J, Brochu M, Butterfield M, Ashikaga T, Poehlman ET. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Sterl 2000;73:61-5.
34. Brochu M, Starling RD, Tchernof A, Mathews DE, Garcia-Rubi E, Poehlman ET. Visceral adipose tissue is an independent correlate of glucose disposal in older postmenopausal women. J Clin Endocrinol Metab 2001;85:2378-84.
35. Goran MI, Bergman RN, Gower BA. Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res 2001;9:423-31.
36. Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiason I. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab 2001:86:744-9.
37. Purnell JQ, Kahn SE, Schwartz RS, Brunzell JD. Relationship of insulin sensitivity and apoB levels to intra-abdominal fat in subjects with combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2001;21:567-72.
38. Raji A, Seeley EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366-71.
39. Ross R, Aru J, Freman J, Hudson R, Janssen I. Abdominal obesity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002;282:E657-E663.
40. Ross R, Freeman J, Hudson R, Janssen I. Abdominal obesity, muscle composition and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002;87:5044-51.
41. Cnop M, Landchild MJ, Vidal J et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 2002;51:1005-15.
42. Cruz ML, Bergman RN, Coran MI. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 2002;25:1631-6.
43. Can SK, Krikeos AD, Poynten AM et al. Insulin action, regional fat, and myocyte lipid; altered relationships with increased adiposity. Obes Res 2003;11:1295-305.
44. Tulloch-Reid MK, Hanson RL, Sebring NG et al. Both subcutaneous and visceral adipose tissues correlate highly with insulin resistance in African Americans. Obes Res 2004;12:1352-9.
45. Rattarasarn C, Leelawattan R, Soonthornpun S, Setasuban W, Thamprasit A. Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais. J Clin Endocrinol Metab 2004;89:6266-70.
46. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal, subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-8.
47. Kissebah AH, Vydelingum N, Murray R et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-60.
48. Sparrow D, Borkan GA, Gerzof SC, Wisniewski C, Silbert CK. Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 1986;35:411-15.
49. Bjorntorp P. Adipose distribution, plasma insulin, and cardiovascular disease. Diabetes Metab 1987;13:381-5.
50. Despres JP, Nadeau A, Tremblay A, Ferland M, Lupien PJ. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989;38:304-09.
51. Pouliot MC, Despres JP, Nadeau A et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41:826-34.
52. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiological Reviews 1994;74:761-811.
53. Gautier JF, Milner MR, Elam E, Chen K, Ravussin E, Pratley RE. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion. Diabetologia 1999;42:28-34.
54. Tulloch-Reid MK, Williams DE, Looker HC, Hanson RL, Knowler WC. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Diabetes Care 2003;26:2556-61.
55. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 1990;39:283-99.
56. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-63.
57. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, Cruz A. Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men: the European fat distribution study. Atherosclerosis 1991;86:251-60.
58. Folsom AR, Li Y, Pao X et al. Body mass, fat distribution and cardiovascular risk factors in a lean population of south China. J Clin Epidemiol 1994;47:173-81.
59. Sakurai Y, Kono S, Shinchi K et al. Relation of waist-hip ratio to glucose tolerance, blood pressure, and serum lipids in middle-aged Japanese males, Int J Obes 1995;19:632-7.
60. Takami R, Takeda N, Hayashi M et al. Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. Diabetes Care 2001;24:1248-52.
61. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in Whites and African-Americans. Diabetes Care 1996;19:414-18.